Cancer vaccines : new research /

Cancer vaccines : new research /

42

Bibliografski detalji
Glavni autor:	Elliot, Nathan
Format:
Jezik:	eng
Izdano:	New York, NY : Nova Science Publisher, 2006
Teme:	Cancer vaccines Cancer

Slični predmeti

Cancer vaccines : from research to clinical practice /
od: Bot, Adrian, editor, i dr.
Izdano: (2011)

Cancer vaccines : methods and protocols /
od: Lawman, Michael J. P., editor, i dr.
Izdano: (2014)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
od: Alireza Shariati, i dr.
Izdano: (2024-12-01)

Vaccination in children with cancer
od: D. Y. Kachanov, i dr.
Izdano: (2022-11-01)

Tumor immunology and cancer vaccines /
od: Khleif, Samir
Izdano: (2005)

Tumor immunotherapy and cancer vaccines /
od: Dennis, Eden, editor
Izdano: (2015)

Cancer vaccines and tumor immunity /
od: Orentas, Rimas, i dr.
Izdano: (2008)

Tumor immunology : immunotherapy and cancer vaccines /
od: Dalgleish, A. G. (Angus G.), i dr.
Izdano: (1996)

The Past, Present, and Future of Cervical Cancer Vaccines
od: Alexander C. Lien, i dr.
Izdano: (2025-02-01)

Advances in nucleic acid-based cancer vaccines
od: Hung-Chun Liao, i dr.
Izdano: (2025-01-01)

DNA vaccines as promising immuno-therapeutics against cancer: a new insight
od: Alireza Shariati, i dr.
Izdano: (2025-01-01)

General principles of tumor immunotherapy : basic and clinical applications of tumor immunology /
od: Kaufman, Howard L., i dr.
Izdano: (2007)

Vaccination Status and Effectiveness of COVID‐19 Vaccines in Patients with Prostate and Bladder Cancer
od: Ali Nowroozi, i dr.
Izdano: (2024-08-01)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
od: Ramirez-Valdez, RA
Izdano: (2021)

Mycobacterium spp. exposure, childhood vaccinations, and early childhood brain and CNS cancers
od: Samer Singh, i dr.
Izdano: (2025-01-01)

Challenges and New Directions in Therapeutic Cancer Vaccine Development
od: Danjie Pan, i dr.
Izdano: (2024-11-01)

Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook
od: Wenhao Zhou, i dr.
Izdano: (2024-12-01)

Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies
od: Fernando Augusto Siqueira Mathias, i dr.
Izdano: (2025-01-01)

Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges
od: Adriana Novakova, i dr.
Izdano: (2025-01-01)

Potential and development of cellular vesicle vaccines in cancer immunotherapy
od: Wenxi Zhao, i dr.
Izdano: (2025-01-01)

Safety and efficacy of COVID-19 vaccines in children and adolescents with cancer
od: Nilgün Kurucu, i dr.
Izdano: (2024-10-01)

Impact of social determinants and medical mistrust on parent-child HPV vaccination in economically disadvantaged communities: implications for cancer prevention
od: Marcelo M. Sleiman, i dr.
Izdano: (2025-01-01)

Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine acceptance in college-going students: Institutional-based cross-sectional study from Bihar State
od: Ekta Krishna, i dr.
Izdano: (2025-01-01)

Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)
od: Caterina Lapenta, i dr.
Izdano: (2024-09-01)

Telomerase-based vaccines: a promising frontier in cancer immunotherapy
od: Sogand Vahidi, i dr.
Izdano: (2024-12-01)

Knowledge and attitude among Egyptian medical students regarding the role of human papillomavirus vaccine in prevention of oropharyngeal cancer: a questionnaire-based observational study
od: Mohammed. N. Abdelaziz, i dr.
Izdano: (2025-01-01)

Cancer vaccines: platforms and current progress
od: Wanting Lei, i dr.
Izdano: (2025-01-01)

COVID-19 Vaccine Hesitancy Among Pediatric Oncology and Bone Marrow Transplant Patients
od: Sarah A. O’Neill, i dr.
Izdano: (2024-12-01)

The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
od: Chris T. P. Do, i dr.
Izdano: (2024-09-01)

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
od: Dariush Haghmorad, i dr.
Izdano: (2025-03-01)

Truncated chicken anemia virus-VP3 as a potential anti tumour vaccine
od: Lim, Shen Ni
Izdano: (2012)

Big data analysis of influenza vaccination and liver cancer risk in hypertensive patients: insights from a nationwide population-based cohort study
od: Chun-Chih Chiu, i dr.
Izdano: (2025-02-01)

Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
od: Carmine D'Amico, i dr.
Izdano: (2025-03-01)

VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens
od: Ibel Carri, i dr.
Izdano: (2025-01-01)

Personalized cancer vaccine design using AI-powered technologies
od: Anant Kumar, i dr.
Izdano: (2024-11-01)

Persistent oral HPV infections – Are we vaccinating against the right HPV types to prevent HPV-related oropharyngeal cancer?
od: Annika Antonsson
Izdano: (2024-06-01)

Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
od: Ibeanu GC, i dr.
Izdano: (2024-12-01)

Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland
od: Mikołaj Bartoszkiewicz, i dr.
Izdano: (2021-09-01)

Challenges of COVID-19 vaccination in patients with cancer
od: Jia Siyue, i dr.
Izdano: (2022-03-01)

Human Papillomavirus-Related Cancer Vaccine Strategies
od: Xia Cai, i dr.
Izdano: (2024-11-01)